Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Invo Bioscience Inc (NQ: INVO )

0.8901 -0.0699 (-7.28%)
Streaming Delayed Price Updated: 10:56 AM EDT, Jun 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Invo Bioscience Inc

Exploring Emerging Companies with Key Developments Garnering Attention: INBS, INVO, VTAK, RCAT, GCTK
Via AB Newswire
INVO Bioscience Inc. (NASDAQ: INVO) is One of Wednesday Morning’s Most Active Stocks
Via Investor Brand Network
NAYA Biosciences To Acquire Clinical Stage Gene Therapy Program for Leber's Hereditary Optic Neuropathy (LHON)
From NAYA Biosciences
Via GlobeNewswire
INVO Bioscience Files S-4 Registration and Preliminary Joint Proxy Statements in Connection with Merger with NAYA Biosciences, NAYA Announces New Board Directors
From NAYA Biosciences
Via GlobeNewswire
INVO Bioscience Inc. (NASDAQ: INVO) Leading the Way in Tuesday Trading Based on Percentage Gain
Via Investor Brand Network
BestGrowthStocks.Com Issues Comprehensive Analysis Regarding INVO Biosciences Merger
Best Growth Stocks, a leading independent equity research and corporate access firm focused on finding and reporting on the best growth stocks utilizing exclusive ai-assisted research recently issued a... 
Via TheNewswire.com
INVO BIOSCIENCE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of INVO Bioscience, Inc. - INVO
From Kahn Swick & Foti, LLC
Via Business Wire
INVO Bioscience Inc. (NASDAQ: INVO) is One of Monday Morning’s Most Active Stocks
Via Investor Brand Network
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: EngageSmart, Inc. (NYSE – ESMT), Hess Corporation (NYSE – HES), Textainer Group Holdings Limited (NYSE – TGH), INVO Bioscience, Inc. (Nasdaq – INVO)
From Brodsky & Smith LLC
Via GlobeNewswire
Why the Relapsed/Refractory Acute Myeloid Leukemia Market is Expected to Witness Revolutionary Developments
EQNX::TICKER_START (NASDAQ:TCBP),(NYSE:CVM),(NASDAQ:INVO),(NASDAQ:SNY),(NYSE:PFE) EQNX::TICKER_END 
Via FinancialNewsMedia
Exposures Product Safety
INVO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of INVO Bioscience, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
INVO Bioscience Eyes +20 U.S. Cities To Expand Rollout Of Advanced Infertility Treatment 'INVO Centers'
SAN FRANCISCO, CA / ACCESSWIRE / February 9, 2022 / Today, the global fertility market is a multi-billion industry, yet remains severely underserved, with estimates suggesting more than 90% of couples... 
From INVO Bioscience, Inc.
Via AccessWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.